CASE 01: Simultaneous Re-MitraClip for functional Mitral Regurgitation & MitraClip for Tricuspid regurgitation -Dr.Georg NICKENIG - Dr.Nikos WERNER
This procedure concerns an 80 years old female , with past medical history of edge-to-edge mitral repair (MitraClip) 7 years ago,
Presenting recurrent severe Heart Failure III NYHA and significant mitral regurgitation that will be treated with Re-Mitra-Clip repair .Also she prensts a severe Tricuspid regurgitation that was treated during the same session.
Strategy Plan
Imaging studies
-
Coronary angiography: 2 vessels CAD
-
Echo: LV EF 41%, moderate to severe mitral regurgitation,severe Tricuspid regurgitation.
-
Nuclear testing :postive ischemia and viability
Clinical indication
-
Heart failure III NYHA (Log EUROSCORE:20.1% - STS SCORE:12.1%)
-
Heart Team decision
Planned Procedure
-
Edge-To-Edge mitral regurgitation repair with MitraClip system.
-
Same session Edge-to-Edge tricuspid repair with MitraClip system.
CASE 02: Complex Retrograde RCA ostial CTO PCI -Dr.Paul Hsien-Li Kao - Dr.Nicos WEINSTEIN
This procedure concerns an 73 years old female , Diabetic with history of coronary three vessels disease managed with PCI, moderate Aortic stenosis and Chronic kidney disease,
Presenting excertional dyspnea II NYHA and Chronic total occlusion of the RCA that was failed to opening attempts last year, she is admitted for a sencond RCA CTO attempt.
Strategy Plan
Imaging studies
-
3 vessels disease, LAD and Lcx patent
-
Echo: LV EF 40%, inferior hypokinesia
-
Stressecho testing :postive i
Clinical indication
-
Heart failure III NYHA
-
Positive viability
Planned Procedure
-
Retrograd attempts first startegy.
CASE 03: Transfemoral TAVI in Pure Aortic regurgitation -Dr.Grube EBERHARD - Dr.Nikos WERNER
This procedure concerns a 55 years old male , with past medical history of Liver transplantation secondary to chronic hepatitis C and hepatocellular carcinoma, Chronic kidney disease.
Presenting recurrent Heart Failure II NYHA and svere aortic regurgitation treated with Transfemoral TAVI with implanatation of two Evolut-R valves.
Strategy Plan
Imaging studies
-
Echo: LV EF 56%, Severe aortic regurgitation, moderate to severe mitral regurgitation,LEDD:74mm
-
CT scann : area 520mm² , perimeter:82.7mm , annulus: 24.X28.5mm
Clinical indication
-
Severe aortic regurgitation (Log EUROSCORE:1.51% - STS SCORE:1.45%)
-
Heart Team decision
Planned Procedure
-
Transfemoral TAVI with 34mm Evolut-R
Shooting date : 2018-02-23
Last update : 2018-07-20
Martin V. Where can I get a pair of lead glasses like the one Dr. Eberhard wears?